11 January, 2001 |
| 09:49 |
Re: RA Department of the future |
james.meakings |
| 09:49 |
RA Department of the future |
Tom Sam |
15 January, 2001 |
| 18:46 |
Class 100,000 regulations |
Douglas Fulton |
| 22:00 |
Re: Class 100,000 regulations |
Cgmpman |
16 January, 2001 |
| 16:29 |
Re: Class 100,000 regulations |
tompoe |
17 January, 2001 |
| 08:14 |
RE: Class 100,000 regulations |
Peter Geffen |
19 January, 2001 |
| 07:42 |
Sterility testing of infusions (form-fill-seal) |
Steve Dias |
| 14:23 |
Re: Sterility testing of infusions (form-fill-seal) |
Bob Snider |
21 January, 2001 |
| 09:34 |
Sampling of bulk active |
Mummun Vergis |
| 15:08 |
Re: Sampling of bulk active |
Cgmpman |
| 15:08 |
Re: Sampling of bulk active |
michael h. anisfeld |
| 19:54 |
Re: Sampling of bulk active |
Stanley110 |
30 January, 2001 |
| 07:57 |
Quality Systems used by Regulatory Affairs Departments |
Tom Sam |
| 09:41 |
Re: Quality Systems used by Regulatory Affairs Departments |
Bulcsu Herenyi |
04 February, 2001 |
| 20:06 |
Bioavailability requirements for IM drugs |
Ilbeyi Agabeyoglu |
05 February, 2001 |
| 12:49 |
Endotoxin Test for Plastic Granules |
Steve Dias |
| 17:51 |
Re: Endotoxin Test for Plastic Granules |
michael h. anisfeld |
06 February, 2001 |
| 07:57 |
Re: Interim SOPs |
Donald P. Cox |
| 22:43 |
Re: Interim SOPs |
michael h. anisfeld |
07 February, 2001 |
| 08:06 |
Re: Interim SOPs |
HoroRL |
| 13:58 |
Re: Interim SOPs |
michael h. anisfeld |
| 16:37 |
Re: Interim SOPs |
HoroRL |
15 February, 2001 |
| 17:50 |
Any negatives in using a His tag |
Ivan Salazar |
20 February, 2001 |
| 06:30 |
Simple Fail-Safe Homebased E-Biz !! |
mk.joseph |
| 18:54 |
Re: control samples |
SANJAY GORANA |
23 February, 2001 |
| 17:50 |
Informed Consent Form |
Stefan J. Ochalski |
24 February, 2001 |
| 05:44 |
At Last, Herbal V, the all natural alternative to Viagra! |
HerbalV |
27 February, 2001 |
| 20:35 |
Re: Informed Consent Form |
TJMULLINS |
28 February, 2001 |
| 17:32 |
RE: Informed Consent Form |
Kupiec, Raun |
| 23:03 |
RE: Informed Consent Form |
Harder, Joel |
01 March, 2001 |
| 07:51 |
Analytical method validation |
Shailesah Gajjar |
| 08:22 |
RE: Analytical method validation |
lt09 |
| 21:50 |
RE: Informed Consent Form |
TJMULLINS |
09 March, 2001 |
| 13:13 |
Guidelines on Japanese Labelling |
Frederic Ivanow |
10 March, 2001 |
| 21:07 |
Non-sterile production facilities |
Roger Lachance |
11 March, 2001 |
| 08:51 |
Re: Non-sterile production facilities |
michael h. anisfeld |
| 08:51 |
Re: Guidelines on Japanese Labelling |
michael h. anisfeld |
15 March, 2001 |
| 13:53 |
Re: Guidelines on Japanese Labelling |
Anna O'Mahony |
21 March, 2001 |
| 23:34 |
European Centralised Procedure For MAA |
Helen Ryan |
22 March, 2001 |
| 14:53 |
Re: European Centralised Procedure For MAA |
Tom McMahon |
26 March, 2001 |
| 08:03 |
Re: European Centralised Procedure For MAA |
Malcolm Ross |
| 10:50 |
Re: European Centralised Procedure For MAA |
Brian MATTHEWS |
| 10:52 |
Re: European Centralised Procedure For MAA |
Ryan, Helen |
| 14:21 |
No Subject |
Ryan, Helen |
| 15:21 |
Re: European Centralised Procedure For MAA |
Malcolm Ross |
| 15:22 |
Re: European Centralised Procedure For MAA |
Malcolm Ross |
| 15:22 |
Re: European Centralised Procedure For MAA |
Lassoff, Peter |
| 15:57 |
RE: European Centralised Procedure For MAA |
Lassoff, Peter |
| 18:59 |
Re: European Centralised Procedure For MAA |
Brian MATTHEWS |
| 18:59 |
Placebo composition |
Patricia Stotland |
27 March, 2001 |
| 07:46 |
Re: Placebo composition |
Jay2rees |
28 March, 2001 |
| 18:40 |
DDX |
Diane Delahooke |
29 March, 2001 |
| 15:14 |
Re: DDX |
Brian MATTHEWS |
| 15:15 |
Re: DDX |
michael h. anisfeld |
| 15:15 |
RE: DDX |
Lassoff, Peter |
04 April, 2001 |
| 16:12 |
FDA Inspection Schedule |
Prefered User #2 Temp User |
| 20:15 |
GLP |
Ivan Salazar |
05 April, 2001 |
| 15:55 |
Re: GLP |
Bulcsu Herenyi |
| 17:59 |
Re: FDA Inspection Schedule |
michael h. anisfeld |
| 18:00 |
Re: RegAffairs Digest - 05/04/01 |
TJMULLINS |
| 18:11 |
Re: RegAffairs Digest - 05/04/01 |
TJMULLINS |
| 21:53 |
Particule matter |
Marisel Quintana |
07 April, 2001 |
| 03:59 |
Genetically Modified Foods as Source Materials for Excipients |
Bob Snider |
09 April, 2001 |
| 16:13 |
Genetically-modified foods |
Patricia Stotland |
| 16:15 |
RE: GLP |
Lassoff, Peter |
24 April, 2001 |
| 16:33 |
European pharmaceutical regulations |
Tom Thorpe |
| 19:12 |
Limits of ethanol in medicines |
beatriz.fernandes |
25 April, 2001 |
| 08:23 |
Re: Limits of ethanol in medicines |
Brian MATTHEWS |
| 08:25 |
Re: Limits of ethanol in medicines |
Nasshia Cain |
| 09:22 |
Re: European pharmaceutical regulations |
hahn.kd |
| 13:09 |
Re: Limits of ethanol in medicines |
Donald P. Cox |
02 May, 2001 |
| 17:00 |
IMPURITIES IN API |
Ketan Agravat |
| 17:08 |
Use Of Novel Pharmaceutical Excipients |
Ryan, Helen |
| 18:54 |
RE: Use Of Novel Pharmaceutical Excipients |
Lassoff, Peter |
| 22:11 |
Re: IMPURITIES IN API |
Cgmpman |
03 May, 2001 |
| 09:33 |
Re: IMPURITIES IN API |
Malcolm Ross |
| 09:33 |
RE: Use Of Novel Pharmaceutical Excipients |
Peter Geffen |
04 May, 2001 |
| 10:45 |
Use Of Novel Pharmaceutical Excipients |
Ryan, Helen |
| 12:46 |
RE: Use Of Novel Pharmaceutical Excipients |
Lassoff, Peter |
07 May, 2001 |
| 22:02 |
Antioxidants - Testing Requirements |
Rajender Singh |
08 May, 2001 |
| 08:13 |
RE: Antioxidants - Testing Requirements |
Dahibhate . P. |
| 10:39 |
RE: Antioxidants - Testing Requirements |
Lassoff, Peter |
09 May, 2001 |
| 05:49 |
Re: Antioxidants - Testing Requirements |
Stanley110 |
10 May, 2001 |
| 06:38 |
Re: RE: Use Of Novel Pharmaceutical Excipients |
Raj |
11 May, 2001 |
| 17:17 |
Medicines Control Agency guideline on CTX/CTC applications |
Brian MATTHEWS |
| 17:17 |
Novel Excipients |
Ryan, Helen |
| 21:49 |
Re: Novel Excipients |
Bob Snider |
| 21:50 |
Re: Novel Excipients |
Tom McMahon |
| 21:50 |
Re: Novel Excipients |
Brian MATTHEWS |
12 May, 2001 |
| 09:10 |
Re: Novel Excipients |
HoroRL |
| 18:31 |
Re: Novel Excipients |
Brian MATTHEWS |
14 May, 2001 |
| 09:07 |
Novel Excipients |
Ryan, Helen |
26 May, 2001 |
| 10:39 |
euro dmf |
r.madhavacharyulu |
| 15:22 |
cytotoxic drugs |
Madhavi |
27 May, 2001 |
| 00:01 |
RE: euro dmf |
Lassoff, Peter |
| 09:59 |
RE: euro dmf |
Peter Geffen |
28 May, 2001 |
| 22:26 |
Response factors |
Madhavi |
| 22:26 |
Centrifuge lots |
Madhavi |
| 22:26 |
Re: euro dmf |
Brian MATTHEWS |
29 May, 2001 |
| 00:29 |
Re: Response factors |
Dipak Saptarshi |
